Načítá se...
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
Aberrant DNA methylation is an epigenetic hallmark of melanoma, known to play important roles in melanoma formation and progression. Recent advances in genome-wide methylation methods have provided the means to identify differentially methylated genes, methylation signatures, and potential biomarker...
Uloženo v:
| Vydáno v: | Clin Epigenetics |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381063/ https://ncbi.nlm.nih.gov/pubmed/28396701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-017-0332-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|